Benevis, LLC and 133 affiliated Kool Smiles dental clinics have agreed to pay more than $23.9 million to the federal government and various state Medicaid programs to settle a series of False Claims Act lawsuits alleging that fraudulent and harmful dental procedures were performed on children in order to maximize profits. This is the second largest False Claims Act whistleblower recovery against a dental provider in U.S. history.
Berger Montague is pleased to announce that on December 29, 2017, affiliates of American Gypsum Co., National Gypsum Co., and PABCO Building Products LLC agreed to pay a class of drywall direct purchasers $125 million to settle price-fixing allegations. This latest settlement brings the total amount of settlements for the class to $190.7 million.
Berger Montague has selected Sherrie R. Savett to serve as Chairwoman of the firm in 2018. Ms. Savett is the first woman to hold the chair position in Berger Montague's 48-year history. The firm also promoted two attorneys, Ellen T. Noteware and Caitlin G. Coslett, to shareholder status.
Berger Montague, has announced an investigation into an alleged $1.2 billion Ponzi scheme operated by Robert H. Shapiro through Woodbridge Group of Companies, LLC, Woodbridge Structured Funding, LLC, RS Protection Trust and WMF Management, LLC. According to the SEC, Shapiro operated Woodbridge Group of Companies as a Ponzi scheme bilking investors out of as much as $1.2 billion.
Berger Montague announced today that the Securities and Exchange Commission accused Behavioral Recognition Systems Inc. and its ex-CEO, Ray C. Davis, of federal securities law violations in an action filed in the U.S. District Court for the Southern District of Texas. The SEC lawsuit was filed on behalf of investors who purchased or otherwise acquired BRS securities between January 2013 and July 2015.
Late yesterday, Judge Joan N. Ericksen denied in its entirety Boston Scientific Corporation's motion to dismiss a whistleblower lawsuit involving allegedly defective cardiac defibrillators. The case will now move into discovery.
Berger Montague announced today that Genocea Biosciences, Inc. (NASDAQ: GNCA) and some of its senior executives have been accused of federal securities law violations in a class action filed in the U.S. District Court for the District of Massachusetts.
The emergency relief program offers cash reimbursement to individuals who have incurred financial hardship as a result of the breach.
The complaints allege that Experian and TransUnion, two of the "big three" U.S. consumer reporting agencies, willfully violated the Fair Credit Reporting Act ("FCRA") by reporting tax liens that were already paid and failing to follow reasonable procedures to ensure that the tax lien information they reported was as accurate as possible.